Celldex Therapeutics Inc (CLDX)
36.26
-0.76
(-2.05%)
USD |
NASDAQ |
Apr 25, 16:00
36.29
+0.03
(+0.08%)
Pre-Market: 20:00
Celldex Therapeutics Price to Book Value: 4.723 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.723 |
| April 24, 2024 | 4.822 |
| April 23, 2024 | 4.920 |
| April 22, 2024 | 5.060 |
| April 19, 2024 | 4.947 |
| April 18, 2024 | 5.019 |
| April 17, 2024 | 5.162 |
| April 16, 2024 | 5.028 |
| April 15, 2024 | 5.089 |
| April 12, 2024 | 5.112 |
| April 11, 2024 | 5.323 |
| April 10, 2024 | 5.105 |
| April 09, 2024 | 5.291 |
| April 08, 2024 | 5.176 |
| April 05, 2024 | 5.155 |
| April 04, 2024 | 5.154 |
| April 03, 2024 | 5.256 |
| April 02, 2024 | 5.361 |
| April 01, 2024 | 5.424 |
| March 28, 2024 | 5.467 |
| March 27, 2024 | 5.443 |
| March 26, 2024 | 5.346 |
| March 25, 2024 | 5.398 |
| March 22, 2024 | 5.469 |
| March 21, 2024 | 5.342 |
| Date | Value |
|---|---|
| March 20, 2024 | 5.490 |
| March 19, 2024 | 5.274 |
| March 18, 2024 | 5.335 |
| March 15, 2024 | 5.472 |
| March 14, 2024 | 5.538 |
| March 13, 2024 | 5.903 |
| March 12, 2024 | 5.998 |
| March 11, 2024 | 6.062 |
| March 08, 2024 | 6.240 |
| March 07, 2024 | 6.117 |
| March 06, 2024 | 6.324 |
| March 05, 2024 | 6.514 |
| March 04, 2024 | 6.605 |
| March 01, 2024 | 6.758 |
| February 29, 2024 | 6.260 |
| February 28, 2024 | 6.691 |
| February 27, 2024 | 6.648 |
| February 26, 2024 | 6.282 |
| February 23, 2024 | 4.917 |
| February 22, 2024 | 4.877 |
| February 21, 2024 | 4.913 |
| February 20, 2024 | 5.015 |
| February 16, 2024 | 4.982 |
| February 15, 2024 | 4.793 |
| February 14, 2024 | 4.723 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2808
Minimum
Aug 05 2019
14.28
Maximum
Sep 23 2021
3.979
Average
4.171
Median
Feb 03 2021
Price to Book Value Benchmarks
| ThermoGenesis Holdings Inc | -- |
| Perspective Therapeutics Inc | 12.49 |
| Electromed Inc | 3.451 |
| Xtant Medical Holdings Inc | 2.286 |
| Asensus Surgical Inc | 1.962 |
Price to Book Value Related Metrics
| PS Ratio | 255.23 |
| PEG Ratio | -0.56 |
| Price | 36.26 |
| Earnings Yield | -8.05% |
| Market Cap | 2.027B |
| PEGY Ratio | -0.56 |